Boosting Sustainability and Efficiency in Pharma Manufacturing

Published: 4-Apr-2025

How Can Innovative Raman Spectroscopy Increase Sustainability and Efficiency Efforts in Pharmaceutical Manufacturing in Both Incoming Raw Materials Testing and Final Product Testing?

Date: 14 May 2025

Time: 15:00 BST | 16:00 CEST | 10:00 EDT

Organiser: Agilent in partnership with Manufacturing Chemist

REGISTER HERE

Trending Articles

  1. Cleanroom Technology Conference UK 21–22 May 2025 | Conference and Exhibition | Birmingham, UK
  2. CPhI North America 20–22 May 2025 | Exhibition | Pennsylvania, US
  3. Boosting Sustainability and Efficiency in Pharma Manufacturing 14 May 2025 | Virtual
  4. BIO International Convention 3-6 June, 2024 | Convention | Boston, US
  5. POWTECH 23-25 September 2025 | Exhibition | Nuremberg, Germany

You may also like

Boosting Sustainability and Efficiency in Pharma Manufacturing

14 May 2025 | Virtual
Manufacturing

Modernising the USP HPLC method for acetaminophen and caffeine tablets

New approach to USP <621> guidelines delivers faster analysis, reduced solvent use, and improved performance with no revalidation required.
Regulatory

Characterising nitrosamine impurities in sartan compounds with an Agilent GC/TQ system with hydrogen carrier gas

Exploring the analysis of nitrosamine contamination in sartan drugs using Agilent's innovative triple quadrupole (TQ) GC/MS system with hydrogen carrier gas
Research & Development

Transmission Raman Spectroscopy - access the webinar series today

Offering significant advantages for bulk, quantitative and non-destructive analysis, Transmission Raman Spectroscopy is a preferred choice for applications where surface analysis is insufficient or prone to errors. Speakers from Agilent, Novartis Pharma, AstraZeneca, Bristol-Myers Squibb and AbbVie go deeper in this FREE webinar series
Manufacturing

Dissolution of an immediate release nanoparticle formulation using the NanoDis system

An efficient dissolution method to aid in nanoparticle drug development
Analysis

Agilent and GenNext integrate digital technologies to accelerate biopharma research

The combination of the two systems will allow biopharmaceutical researchers to better analyse a protein's structure and function in the lab
Manufacturing

Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA

The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
Subscribe now